After chemotherapy in patients with advanced lung adenocarcinoma, there is an improvement in pulmonary radiographic manifestations, disappearance of arthritic symptoms, and a decline in the tumor marker carcinoembryonic antigen (CEA), further supporting the notion that PFPAS is a paraneoplastic disorder [16]. Here, CEACAM5 is linked to lung adenocarcinoma.